Diabetic Ketoacidosis After COVID-19 Vaccine in Patients with Type 1 Diabetes Mellitus

被引:0
|
作者
Albedaiwi, Fahad Bedaiwi [1 ]
Alshammari, Manar [2 ]
Algeffari, Metab [3 ]
Alfouzan, Abdulmajeed [4 ]
Alfouzan, Yasmeen [4 ]
Siddiq, Hassan [1 ]
Hussein, Omaima [1 ]
机构
[1] Diabet & Endocrinol Ctr, Buraydah 52366, Al Qassim, Saudi Arabia
[2] Royal Commiss Hlth Serv Program, Jubail Ind City, Saudi Arabia
[3] Qassim Univ, Dept Family & Community Med, Coll Med, Buraydah, Saudi Arabia
[4] Qassim Univ, Coll Med, Buraydah, Al Qassim, Saudi Arabia
关键词
COVID-19; Vaccine; T1DM; DKA; Bicarbonate; ADOLESCENTS;
D O I
10.5812/ijem-135866
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The coronavirus disease 2019 (COVID-19) vaccine is one of the few vaccines that obtained emergency authorization to combat the fatal pandemic. Despite the fact that some available literature addressed its short-term side effects, there are still limitations on its effects on type 1 diabetes mellitus (T1DM). Objectives: The aim of the present study was to assess the association between COVID-19 vaccination and diabetic ketoacidosis (DKA) among individuals with T1DM. Additionally, the study aimed to determine the effects of the vaccine on glucose control, variability, and risk of hypoglycemia. Methods: This retrospective study was conducted at King Fahad Specialist Hospital (KFSH) in Qassim Region, Saudi Arabia. Diabetic ketoacidosis cases admitted to the hospital within February 2020 and August 2022 were included in the study based on specific inclusion criteria. Finally, a total of 49 patients were included in statistical analyses. Results: Out of the 62 patients admitted to the hospital, 49 met the diagnostic criteria for DKA and agreed to participate in the study. The majority of the remaining patients (n = 13) refused to participate, and only a few of them lacked complete documentation. Of the 49 patients who were included in the study, 46 cases had a history of T1DM; nevertheless, 3 patients were newly diagnosed with T1DM. Additionally, among these participants, 16 (32.7%), 19 (38.8%), and 14 (28.6%) patients had mild, moderate, and severe DKA, respectively. There were 27 male (55.1%) and 22 female (44.9%) patients. About 91% of the patients were vaccinated against COVID-19, 30.6% of whom were vaccinated within 29 days of being diagnosed with DKA. The pH and bicarbonate levels were observed to be significantly high among those who were diagnosed with DKA within 29 days of vaccination, with p-values of 0.031 and 0.037, respectively. Similarly, pH and random blood sugar (RBS) were observed to be significantly higher among the vaccinated patients than in the non-vaccinated subjects (P = 0.044 and P = 0.032, respectively). Conclusions: The study findings revealed that some of the DKA indicators were evident among the vaccinated patients. However, larger-scale and multi-center studies are recommended in order to have more conclusive evidence and generalize the findings.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Diabetic ketoacidosis in type 2 diabetes mellitus
    Wasada, T
    INTERNAL MEDICINE, 2000, 39 (01) : 1 - 1
  • [42] Diabetic ketoacidosis in type 2 diabetes mellitus
    Puttanna, A.
    Padinjakara, R. N. K.
    PRACTICAL DIABETES, 2014, 31 (04) : 155 - 158
  • [43] COVID-19 vaccine prioritisation for type 1 and type 2 diabetes
    Powers, Alvin C.
    Aronoff, David M.
    Eckel, Robert H.
    LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (03): : 140 - 141
  • [44] Severe Diabetic Ketoacidosis After the Second Dose of mRNA-1273 COVID-19 Vaccine
    Zilbermint, Mihail
    Demidowich, Andrew P.
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2022, 16 (01): : 248 - 249
  • [45] Is it possible to prevent diabetic ketoacidosis at diagnosis of pediatric type 1 diabetes? Lessons from the COVID-19 pandemic
    Moenkemoeller, Kirsten
    Kamrath, Clemens
    Hammersen, Johanna
    Biester, Torben
    Warncke, Katharina
    Pappa, Angeliki
    Fink, Katharina
    Raile, Klemens
    Rohrer, Tilman R.
    Holl, Reinhard W.
    MONATSSCHRIFT KINDERHEILKUNDE, 2021, 169 (05) : 451 - 460
  • [46] Diabetic Ketoacidosis at Onset of Pediatric Type-1 Diabetes Triggered by Covid-19: An Original Case Report
    Benyakhlef, Salma
    Abdellaoui, Wahiba
    Tahri, Abir
    Rouf, Siham
    Latrech, Hanane
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (03)
  • [47] The effect of COVID-19 pandemic restrictions on the frequency of diabetic ketoacidosis at the time of diagnosis in children with type 1 diabetes
    Esen, Ihsan
    Kocaman, Selami
    Acar, Nurdan Yildirim
    Paksoy, Firdevs Dilara
    Okdemir, Deniz
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 490 - 490
  • [48] Lipohypertrophy contributing to severe diabetic ketoacidosis in type 1 diabetes: An increasing problem in the context of the COVID-19 pandemic?
    Smith, Emilia Imogen
    Ciutac, Andra
    Smith, Jamie C.
    CLINICAL CASE REPORTS, 2022, 10 (11):
  • [49] Description of the characteristics of the diabetic ketoacidosis debut in a sample of patients with type 1 diabetes mellitus
    del Villar-Guerra, Pablo
    de Luis-Roman, Daniel
    Gonzalez-Sagrado, Manuel
    del Villar-Galan, Rafael
    MEDICINA CLINICA, 2015, 144 (06): : 280 - 281
  • [50] RISK FACTORS FOR DIABETIC KETOACIDOSIS IN PATIENTS WITH NEW ONSET TYPE 1 DIABETES MELLITUS
    Mencher, Shana R.
    Graeme, Frank R.
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 410 - 410